

Here's a roundup of top developments in the biotech space over the last 24 hours.
You can purchase shares of Adagene (NASDAQ:ADAG) through any online brokerage.
Other companies in Adagene’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Adagene has a consensus price target of $8.40.
The stock price for Adagene (NASDAQ: ADAG) is $2.43 last updated October 21, 2026 at 5:15 PM EDT.
There are no upcoming dividends for Adagene.
Adagene does not have any upcoming earnings scheduled.
There is no upcoming split for Adagene.
Adagene is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Adagene Inc is a platform-driven, clinical-stage biotechnology company focused on the discovery and development of novel antibody-based cancer immunotherapies. The Company leverages computational biology to design and develop novel antibodies....